Related references
Note: Only part of the references are listed.Circulating Concentration of Infliximab and Response to Treatment in Ankylosing Spondylitis: Results From a Randomized Control Study
Roman Krzysiek et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Population pharmacokinetics of infliximab in patients with ankylosing spondylitis
Zhenhua Xu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Maintenance of infliximab treatment in ankylosing spondylitis
Maxime Breban et al.
ARTHRITIS AND RHEUMATISM (2008)
Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation
Mirjam K. de Vries et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab
D Ternant et al.
THERAPEUTIC DRUG MONITORING (2006)
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies.: An open extension of a multicentre study
E Collantes-Estevez et al.
RHEUMATOLOGY (2005)
Efficacy and safety of infliximab in patients with ankylosing spondylitis - Results of a randomized, placebo-controlled trial (ASSERT)
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Share Paper
